Novartis Just Shook Up a Multibillion-Dollar Drug Race. What It Means for Eli Lilly Stock.
Lilly may be impacted by Novartis' pelacarsen flop -- but not by much.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.